Viela Bio Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Viela Bio's estimated annual revenue is currently $23.4M per year.
- Viela Bio received $250.0M in venture funding in March 2018.
- Viela Bio's estimated revenue per employee is $155,000
- Viela Bio's total funding is $250M.
- Viela Bio has 151 Employees.
- Viela Bio grew their employee count by 59% last year.
- Viela Bio currently has 7 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|American Gene T...||$4.7M||30||N/A||N/A||N/A|
What Is Viela Bio?
Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. The Company's portfolio selectively targets shared critical pathways that are the root cause of disease. Led by a team of global leaders in inflammation and autoimmunity, Viela Bio strives to be a fully integrated biotechnology company, helping millions of patients worldwide. Viela Bio is located in Gaithersburg, Maryland. Learn more at www.vielabio.comkeywords:N/A
Number of Employees
Employee Growth %
|Mike Zorzy||Regional Business Director|
|Jim Walker||Regional Business Director, West|
|Bill Litzenberg||Associate Director, Clinical Data Management|
|Steven Saheb||Manager, Business Development|
|Deborah Girma||Clinical Project Manager|
|Michele Gunsior||Principal Scientist|
|Dewei She||Senior Director, Head of Data Sciences at Viela Bio|
|Jodi Karnell||Associate Director|
|Maryam Mazaheri||Associate Director of Technical|
|Matthew Dickson||Director, Head of CMC Partnership at Viela Bio|
Viela Bio News
It's a pivotal moment for the MedImmune spinout, which has put the fate of its first prospective product in regulators' hands.
Gaithersburg's Viela Bio Inc. has crossed another milepost in its race to get its first drug to market. The fast-moving biotech has submitted its ...
August 29, 2019. Viela Bio, the AstraZeneca spin-off biotech, has captured the attention of industry insiders since their $250M Series A investment that launched ...
Viela Bio Funding